Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Classification & Diagnosis of Granulomatosis with Polyangiitis

Harry E. Subramanian, Ravi Sutaria, MD, & Fotios Koumpouras, MD  |  Issue: August 2018  |  August 16, 2018

In addition to small vessel vasculitis and infective endocarditis, ANCA testing can also be positive in inflammatory bowel disease, rheumatoid arthritis, systemic lupus erythematosus, human immunodeficiency virus (HIV) infection, malignancies and as a reaction to certain pharmaceuticals.6 Therefore, it can be incredibly difficult to distinguish between an infective endocarditis with a positive ANCA and an ANCA-associated vasculitis with endocardial involvement.

We describe the case of an elderly woman who presented with historical, physical, laboratory and echocardiographic findings consistent with infective endocarditis, including a vegetation on the mitral valve, who was ultimately determined to have GPA and managed with immunosuppressive therapy.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Figure 1: CT Scan of the Chest

Figure 1: CT Scan of the Chest
A CT scan of the chest obtained without intravenous contrast demonstrates diffuse patchy and groundglass opacifications with upper lobe predominance. These findings are consistent with pulmonary hemorrhage. In addition, bilateral pleural effusions are seen.

Figure 2: Renal Biopsy

Figure 2: Renal Biopsy
Biopsy specimen of the kidney stained with hematoxylin and eosin demonstrates a necrotizing glomerulonephritis with a fibrinous crescent within the glomerulus. Immune-complex deposits were not seen on electron microscopy (image not shown).

Case Report

A 78-year-old Caucasian woman presented to an outside hospital with a one-week history of shortness of breath and diffuse joint pains in her bilateral knees and shoulders. Her medical history included hypertension not controlled by any medications, an appendectomy, multiple family members with rheumatoid arthritis and a five pack-year smoking history. She did not take any medications at home. Three weeks prior to presentation, she underwent a tooth extraction for a dental abscess and was given a course of penicillin.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

On presentation, she was afebrile with a blood pressure of 195/85 mmHg and a heart rate of 150 beats per minute. Further examination demonstrated a III/VI systolic murmur heard across the precordium. A petechial rash was present on the right lower extremity, and splinter hemorrhages and Osler nodes were present on the fingers of both hands. Her laboratory studies were notable for a total leukocyte count of 13,000 cells/μL, and her electrocardiogram (ECG) demonstrated first-degree atrioventricular block. Her urine culture grew Escherichia coli, for which she was started on ceftriaxone.

Blood cultures drawn three days after initiation of ceftriaxone treatment were negative. She subsequently developed a cough productive of mucopurulent sputum that progressed to hemoptysis and hypoxemic respiratory failure, and required endotracheal intubation. A computed tomography (CT) angiogram of the chest ruled out pulmonary embolism, but demonstrated focal consolidations consistent with multifocal pneumonia. A bronchoscopy revealed bleeding from the left upper lobe without any lesions. Trans­esophageal echocardiogram (TEE) demonstrated mitral and aortic valve thickening with a small vegetation on the mitral valve. Infective endocarditis was suspected, and the patient’s antibiotic therapy was broadened to ceftriaxone and vancomycin.

Page: 1 2 3 4 5 6 7 8 | Single Page
Share: 

Filed under:ConditionsVasculitis Tagged with:ANCAantineutrophil cytoplasmic antibodyGPAgranulomatosis with polyangiitis

Related Articles
    Figure 1. A nasal biopsy shows intimal infiltration of the small blood vessels (black arrow).

    Case Illustrates the Difficulty Diagnosing Granulomatosis with Polyangiitis

    June 21, 2018

    Granulomatosis with polyangiitis (GPA) was first described in the British Medical Journal in 1897 by Scottish otolaryngologist Peter McBride.1 GPA is a relatively rare, systemic necrotizing vasculitis that can make diagnosis challenging. The incidence has been estimated anywhere between two and 12 cases per million.2 GPA mainly affects adults between the ages of 45 and…

    Case Report: A Patient on Apremilast Develops Streptococcus Salivarius

    October 18, 2019

    Apremilast was first marketed in March 2014 for the treatment of adults with psoriatic arthritis (PsA). An immuno­modulating drug, which is a small molecule inhibitor of phosphodiesterase 4 (PDE4) specific for cyclic adenosine mono­phosphate (cAMP), apremilast is administered orally. By inhibiting PDE4, intracellular cAMP levels are increased. Although the exact mechanism of action is not…

    Rheumatology’s Architect

    March 1, 2008

    Help the REF lay foundations for our future

    The Granulomatosis of Wegener’s

    May 16, 2011

    Delving deeper into the nonvasculitis aspects of the disease

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences